On-Demand Webinar: 2026 Annual Medicare Update

Whether you’re approaching Medicare eligibility or already enrolled, understanding your options can be challenging. Changes to premiums, coverage, prescription drug plans, and income-related costs can all factor into the decisions you make each year.

In this on-demand webinar, James Blake is joined by Karl Steinlage, CEO of Steinlage Insurance Agency, to discuss important Medicare considerations for 2026. They cover Medicare basics and enrollment options, Medicare Supplement and Medicare Advantage plans, prescription drug coverage, IRMAA and potential appeals, and changes that may affect Medicare and health insurance decisions going forward.

Watch the webinar to learn more about your Medicare options and the considerations to keep in mind as you review your coverage.

 

Speakers
Karl Steinlage
Co-Owner & CEO of Steinlage Insurance Agency

James Blake, CFP®
Wealth Advisor, Brand AMG

Speaker Bios

Karl Steinlage 

Karl Steinlage is a Co-Owner & CEO of Steinlage Insurance Agency, which has been helping families choose the best Medicare Advantage Plans, Medicare Supplements, and Medicare Part D Drug Plans since the 1970s. Karl has been nationally recognized for his work helping clients navigate the maze of Medicare coverage options. 

James Blake, CFP® 

James Blake, CFP® joined Brand Asset Management Group as an advisor in 2019. Prior to beginning his career as an advisor in the financial services industry in 2017, James spent 15 years in orthopedic medical device sales. James has obtained the Series 65 and Series 66. He earned his CERTIFIED FINANCIAL PLANNER™ certification.

Disclosure:

The information herein was obtained from various sources. The information provided is believed to be from reliable sources but no liability is accepted for any inaccuracies or completeness of information provided by third parties. The information in this communication is given as of the date indicated and believed to be reliable. BAMG assumes no obligation to update this information, or to advise on further developments relating to it. This is for information purposes and should not be construed as an investment recommendation. Past performance is no guarantee of future performance.